What is Monogram Health?
Monogram Health operates an innovative renal care model, offering a data-driven suite of clinical managed services designed to improve outcomes for patients with chronic kidney and end-stage renal disease. The company partners with health plans, physician practices, dialysis providers, and integrated health systems to deliver exceptional at-home individualized clinical managed services and nephrology care. Leveraging next-generation artificial intelligence and personalized care planning, Monogram Health aims to delay disease progression, facilitate transitions to dialysis, palliative care, or pre-emptive kidney transplant, and optimize overall health outcomes for patients. The company's operations span 20 states, supported by a national network of hundreds of leading kidney care specialists.
How much funding has Monogram Health raised?
Monogram Health has raised a total of $542M across 3 funding rounds:
Series A
$7M
Series B
$160M
Other Financing Round
$375M
Series A (2020): $7M, investors not publicly disclosed
Series B (2021): $160M led by Humana, TPG, Norwest Venture Partners, and Frist Cressey Ventures
Other Financing Round (2023): $375M supported by CVS Health, SCAN Health Plan, Humana, TPG, Memorial Hermann, and Cigna Ventures
Key Investors in Monogram Health
CVS Health
CVS Health is a major player in the healthcare industry, focused on delivering high-quality, affordable health care and improving consumer health and well-being through its extensive reach and integrated services.
Humana
Humana is a health and well-being company committed to helping people live healthier lives by offering personalized care and community-focused initiatives.
TPG
TPG is a global investment firm specializing in alternative assets, known for its strategic approach to supporting business growth across various industries, including healthcare.
What's next for Monogram Health?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and expansion for Monogram Health. This capital infusion is likely to fuel further development of its AI-driven care models, expansion of its in-home nephrology services, and strengthening of its partnerships across the healthcare ecosystem. The company's focus on transforming renal care delivery positions it to capitalize on the growing need for specialized chronic disease management solutions, potentially leading to broader market penetration and enhanced patient access to advanced care.
See full Monogram Health company page
